You have so much more to think about than CAH

The CAHlibrate Pediatric Study is researching an investigational medication for congenital adrenal hyperplasia (CAH). Take the short questionnaire to see if you or your child may be eligible to participate.

See who may qualify ›

See if you or your child may qualify.

The CAHlibrate Pediatric Study is enrolling volunteers between 14 and 17 years old (inclusive) who have been diagnosed with CAH. Please complete the questionnaire to determine your or your child’s eligibility.

Learn more about the CAHlibrate Pediatric Study.

1
2
3

By answering the following questions, you agree to have this information retained for the duration of the study, and you may be contacted by phone or email (as provided) regarding your interest in study participation only.

This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about this, click here.

1
2
3